Unexpected MH deaths without exposure to inhalation anesthetics in pediatric patients

Paediatric Anaesthesia

Volumn 23, Issue 9, 2013, Pages 851-854

  Brandom, Barbara W ^a   Muldoon, Sheila M ^b  

^a MERCY HOSPITAL OF PITTSBURGH   (United States)

^b Uniformed Services University of the Health Sciences   (United States)

Author keywords

anesthesiology; molecular medicine; muscular diseases; pediatrics; premature mortality; ryanodine receptor calcium release channel

Indexed keywords

DANTROLENE; HALOTHANE; INHALATION ANESTHETIC AGENT; SUXAMETHONIUM;

DRUG EXPOSURE; FEVER; HUMAN; HYPERKALEMIA; INHALATION ANESTHESIA; MALIGNANT HYPERTHERMIA; MEDLINE; METABOLIC ACIDOSIS; MORTALITY; MUSCLE RIGIDITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RESPIRATORY DISTRESS; REVIEW; RHABDOMYOLYSIS; RIGIDITY; SHOCK; SYSTEMATIC REVIEW;

ANESTHESIOLOGY; MOLECULAR MEDICINE; MUSCULAR DISEASES; PEDIATRICS; PREMATURE MORTALITY; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL;

ANESTHESIA, GENERAL; ANESTHETICS, INHALATION; CHILD; CHILD, PRESCHOOL; GENOTYPE; HALOTHANE; HUMANS; MALIGNANT HYPERTHERMIA; NEUROMUSCULAR DEPOLARIZING AGENTS; RHABDOMYOLYSIS; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; SUCCINYLCHOLINE;

EID: 84881547662     PISSN: 11555645     EISSN: 14609592     Source Type: Journal    
DOI: 10.1111/pan.12224     Document Type: Review

References (15)

1. Groom L, Muldoon SM, Tang ZZ, et al,. Identical de novo mutation in the type 1 ryanodine receptor gene associated with fatal, stress-induced malignant hyperthermia in two unrelated families. Anesthesiology 2011; 115: 938-945.
2. Gener B, Burns JM, Griffin S, et al,. Administration of ondansetron is associated with lethal outcome. Pediatrics 2010; 125: e1514-e1517.
3. Tobin JR, Jason DR, Challa VR, et al,. Malignant hyperthermia and apparent heat stroke. JAMA 2001; 286: 168-169.
4. Brown RL, Pollock AN, Couchman KG, et al,. A novel ryanodine receptor mutation and genotype-phenotype correlation in a large malignant hyperthermia New Zealand Maori pedigree. Hum Mol Genet 2000; 9: 1515-1524.
5. Johannsen S, Roewer N, Schuster F,. Ondansetron-induced muscle contractures in malignant hyperthermia-susceptible individuals. Anesth Analg 2012; 115: 925-928.
6. Lavezzi WA, Capacchione JF, Muldoon SM, et al,. Case report: death in the emergency department: an unrecognized awake malignant hyperthermia-like reaction in a six-year-old. Anesth Analg 2013; 116: 420-423.
7. Lehmann-Horn F, Jurkat-Rott K,. Nonanesthetic malignant hyperthermia. Anesthesiology 2011; 115: 915-917.
8. Carsana A,. Exercise-induced rhabdomyolysis and stress-induced malignant hyperthermia events; association with malignant hyperthermia susceptibility, and RYR1 gene sequence variations. ScientificWorldJournal 2013; 2013: 6, Article ID 531465. Available at: http://dx.doi.org/10.1155/2013/531465.
9. Gurnaney H, Brown A, Litman RS,. Malignant hyperthermia and muscular dystrophies. Anesth Analg 2009; 109: 1043-1048.
10. Shukry M, Guruli ZV, Ramadhyani U,. Suspected malignant hyperthermia in a child with lamini alpha 2 (merosin) deficiency in the absence of a triggering agent. Pediatr Anesth 2006; 16: 462-465.
11. Martyn JA, Richsfeld M,. Succinylcholine-induced hyperkalemia in acquired pathologic states: etiologic factors and molecular mechanisms. Anesthesiology 2006; 104: 158-169.
12. Kovarik WD, Morray JP,. Hyperkalemic cardiac arrest after succinylcholine in a child with purpura fulminans. Anesthesiology 1995; 83: 211-213.
13. Bertorini TE, Palmieri GM, Griffin J, et al,. Effect of dantrolene in Duchenne muscular dystrophy. Muscle Nerve 1991; 14: 503-507.
14. Brandom BW, Larach MG, Chen MS, et al,. Complications associated with the administration of dantrolene 1987 to 2006: a report from the North American Malignant Hyperthermia Registry of the Malignant Hyperthermia Association of the United States. Anesth Analg 2011; 112: 1115-1123.
15. Phadke A, Broadman LM, Brandom BW, et al,. Postoperative hyperthermia, rhabdomyolysis, critical temperature, and death in a former premature infant after his ninth general anesthetic. Anesth Analg 2007; 105: 977-980.